Adar1 Capital Management, LLC Spring Works Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 100 shares of SWTX stock, worth $3,714. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$3,714% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$249 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$209 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$143 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$131 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$127 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.32B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...